Patent References 3312590 3721687 InventorsAssigneeApplicationNo. 703821 filed on 07/09/1976US Classes:514/180, 9-position substituted514/957VAPOR EMMITTING COMPOSITIONExaminersPrimary: Roberts, Elbert L.Attorney, Agent or FirmInternational ClassA61K 031/56Foreign Application Priority Data1972-04-20 UKAbstractAn antiinflammatory steroid exhibiting a tendency to crystal growth in suspension in aerosol propellants is contacted with a halogenated hydrocarbon to form a crystalline solvate, which, after removal of some or all of the propellant from the crystals, is reduced to a particle size permitting inhalation into the human bronchial system when dispersed as an aerosol, the micronized crystalline solvate not thereafter exhibiting crystal growth in the aerosol propellant. The solvate is a new composition of matter which has been characterized by I.R. spectra and the aerosol formulation prepared therefrom has valuable therapeutic properties, particularly in the treatment of asthma.Other References
| |